Cargando…

Current and emerging treatment options for myopic choroidal neovascularization

Choroidal neovascularization (CNV) is the main cause of visual impairment in highly myopic patients younger than 50 years of age. There are different treatments for myopic CNV (mCNV), with 5- to 10-year outcomes currently. Chorioretinal atrophy is still the most important determinant factor for visu...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Matri, Leila, Chebil, Ahmed, Kort, Fedra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422283/ https://www.ncbi.nlm.nih.gov/pubmed/25987831 http://dx.doi.org/10.2147/OPTH.S49437

Ejemplares similares

Optical Coherence Tomographic Findings in Berlin’s Edema
por: El Matri, Leila, et al.
Publicado: (2010)

Characteristics of Astigmatism in a Population of Tunisian School-Children
por: Chebil, Ahmed, et al.
Publicado: (2015)

Bevacizumab Injection in Patients with Age-Related Macular Degeneration Associated with Poor Initial Visual Acuity
por: El Matri, Leila, et al.
Publicado: (2012)

Swept Source Optical Coherence Tomography Angiography: Characteristic Findings in Type 3 Macular Neovascularization
por: Matri, Khaled El, et al.
Publicado: (2021)

Identifying mutations in Tunisian families with retinal dystrophy
por: Habibi, Imen, et al.
Publicado: (2016)

Corrigendum: Identifying mutations in Tunisian families with retinal dystrophy
por: Habibi, Imen, et al.
Publicado: (2017)

Single intravitreal ranibizumab for myopic choroidal neovascularization
por: Nor-Masniwati, Saidin, et al.
Publicado: (2011)

Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization
por: Tan, Colin S, et al.
Publicado: (2017)

Spectral domain-optical coherence tomography retinal biomarkers in choroidal neovascularization of multifocal choroiditis, myopic choroidal neovascularization, and idiopathic choroidal neovascularization
por: Gao, Rui, et al.
Publicado: (2021)

Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
por: Wang, Jia-Kang, et al.
Publicado: (2018)

Association between choriocapillaris flow deficit and choroidal neovascularization activity in eyes with myopic choroidal neovascularization
por: Uematsu, Sato, et al.
Publicado: (2021)

Multimodal imaging and diagnosis of myopic choroidal neovascularization in Caucasians
por: Milani, Paolo, et al.
Publicado: (2016)

Result of intravitreal aflibercept injection for myopic choroidal neovascularization
por: Chen, Shih-Lin, et al.
Publicado: (2021)

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
por: Karagiannis, Dimitrios, et al.
Publicado: (2017)

Anti-VEGF treatment for myopic choroid neovascularization: from molecular characterization to update on clinical application
por: Zhang, Yan, et al.
Publicado: (2015)

Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization
por: Chhablani, Jay Kumar
Publicado: (2010)

Vascular endothelial growth factor genetic polymorphisms and susceptibility to age-related macular degeneration in Tunisian population
por: Habibi, Imen, et al.
Publicado: (2014)

Results of Ranibizumab Treatment of the Myopic Choroidal Neovascular Membrane according to the Axial Length of the Eye
por: Stepanov, Alexandr, et al.
Publicado: (2020)

Morphological parameters of myopic choroidal neovascularization as predictive factors of anti-VEGF treatment response
por: Castellino, Niccolò, et al.
Publicado: (2022)

Prognostic value of myopic disk deformation in myopic choroidal neovascularization: A 6-year follow-up study
por: Han, Ye Eun, et al.
Publicado: (2022)

High‑dose aflibercept injection has striking effects on myopic choroidal neovascularization
por: Zhu, Wei, et al.
Publicado: (2023)

Treatment Satisfaction and Well-Being in Patients with Myopic Choroidal Neovascularization Treated with Ranibizumab in the REPAIR Study
por: Amoaku, Winfried M., et al.
Publicado: (2015)

Ranibizumab, Verteporfin Photodynamic Therapy or Observation for the Treatment of Myopic Choroidal Neovascularization: Cost Effectiveness in the UK
por: Claxton, Lindsay, et al.
Publicado: (2014)

VISUAL ACUITY OUTCOMES OF RANIBIZUMAB TREATMENT IN PATHOLOGIC MYOPIC EYES WITH MACULAR RETINOSCHISIS AND CHOROIDAL NEOVASCULARIZATION
por: Ceklic, Lala, et al.
Publicado: (2017)

OCT Analysis of Retinal Pigment Epithelium in Myopic Choroidal Neovascularization: Correlation Analysis with Different Treatments
por: Allegrini, Davide, et al.
Publicado: (2022)

Risk factors for myopic choroidal neovascularization-related macular atrophy after anti-VEGF treatment
por: Bae, Ki Woong, et al.
Publicado: (2022)

Myopic choroidal neovascularisation: current concepts and update on clinical management
por: Wong, Tien Y, et al.
Publicado: (2015)

Three cases of macular retinal detachment exacerbated during follow-up with myopic foveoschisis around myopic choroidal neovascularization()()
por: Sayanagi, Kaori, et al.
Publicado: (2023)

Ten-Year Outcomes of Intravitreal Bevacizumab for Myopic Choroidal Neovascularization: Analysis of Prognostic Factors
por: Mallone, Fabiana, et al.
Publicado: (2021)

RELATIONSHIP BETWEEN MYOPIC CHOROIDAL NEOVASCULARIZATION ACTIVITY AND PERFORATING SCLERAL VESSELS IN HIGH MYOPIA
por: Ruiz-Medrano, Jorge, et al.
Publicado: (2022)

An ImageJ macro tool for OCTA-based quantitative analysis of Myopic Choroidal neovascularization
por: Deshpande, Aadit, et al.
Publicado: (2023)

Long-term remission of myopic choroidal neovascular membrane after treatment with ranibizumab: a case report
por: Kumaran, Neruban, et al.
Publicado: (2009)

Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study
por: Hamilton, Robin D., et al.
Publicado: (2020)

Real-World Treatment Intensity and Patterns in Patients With Myopic Choroidal Neovascularization: Common Data Model in Ophthalmology
por: Bui, Manh-Hung, et al.
Publicado: (2023)

Vascular endothelial growth factor genetic polymorphisms and susceptibility to age-related macular degeneration in Tunisian population
por: Habibi, Imen, et al.
Publicado: (2012)

Subthreshold micropulse laser adjuvant to bevacizumab versus bevacizumab monotherapy in treating diabetic macular edema: one- year- follow-up
por: El Matri, Leila, et al.
Publicado: (2021)

Role of microscope-integrated optical coherence tomography in detecting myopic choroidal neovascularization intraoperatively in a case of myopic rhegmatogenous retinal detachment
por: Kumar, Atul, et al.
Publicado: (2020)

LONG-TERM OUTCOMES OF RANIBIZUMAB TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION IN EAST-ASIAN PATIENTS FROM THE RADIANCE STUDY
por: Tan, Nikolle W., et al.
Publicado: (2018)

Evaluation of 10 AMD Associated Polymorphisms as a Cause of Choroidal Neovascularization in Highly Myopic Eyes
por: Velazquez-Villoria, Alvaro, et al.
Publicado: (2016)

Morphologic Features of Myopic Choroidal Neovascularization in Pathologic Myopia on Swept-Source Optical Coherence Tomography
por: Xie, Jiamin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_baj1cgjp06cvsrcadtf91lp4hd